Cancidas Side Effects
>>>Help Community - Post Your Cancidas Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Cancidas Side Effects
Cancidas Safety Reports reported to FDA
Total Cancidas reports: 162.Cancidas FDA safety alerts: No.
Reported deaths: 87 Reported hospitalizations: 69.
Take Cancidas Side Effects Survey or Share Your Cancidas Story.
Reported Cancidas Side Effects: death, septic shock, respiratory failure, multi-organ failure, systemic candida, hepatic failure, condition aggravated, sepsis, acute myeloid leukaemia, graft versus host disease, bronchopulmonary aspergillosis.
Cancidas Usage.
If you have questions about Cancidas, you can ask a Health Expert or Ask Patient Community about Cancidas.
< Previous Showing 151-162 of 162
Cancidas Side Effects Report #5428412-8Health Professional from FRANCE reported CANCIDAS problem on Aug 17, 2007. Female patient, 69 years of age, was diagnosed with candidiasis, thrombosis prophylaxis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. CANCIDAS dosage: unknown. During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM, AMIODARONE, DANAPAROID, NEFOPAM HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Cancidas Side Effects Report #5429416-1
CANCIDAS problem was reported by a Physician from UNITED STATES on Aug 20, 2007. Male patient, 26 years of age, was diagnosed with hiv infection, respiratory failure and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hiv infection. CANCIDAS dosage: unknown. Patient was hospitalized. Patient died.
Cancidas Side Effects Report #5444930-0
Consumer or non-health professional from KOREA, REPUBLIC OF reported CANCIDAS problem on Aug 22, 2007. Male patient, 60 years of age, was diagnosed with aspergillosis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, acute respiratory distress syndrome, condition aggravated, pneumonia fungal, pulmonary haemorrhage, septic shock. CANCIDAS dosage: 70 MG DAILY IV, 50 MG DAILY IV. During the same period patient was treated with AMIKACIN SULPHATE, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, IMIPENEM, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TEICOPLANIN. Patient was hospitalized and became disabled. Patient died.
Cancidas Side Effects Report #5447687-2
CANCIDAS problem was reported by a Physician from UNITED ARAB EMIRATES on Aug 29, 2007. Male patient, 57 years of age, weighting 176.4 lb, was diagnosed with evidence based treatment, pneumonia, sepsis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, hepatic failure, oesophageal varices haemorrhage, pneumonia, renal failure acute. CANCIDAS dosage: unknown. During the same period patient was treated with MEROPENEM, LINEZOLID, TOBRAMYCIN. Patient was hospitalized and became disabled. Patient died.
Cancidas Side Effects Report #5448052-4
Health Professional from FRANCE reported CANCIDAS problem on Sept 04, 2007. Female patient, 69 years of age, was diagnosed with candidiasis, thrombosis prophylaxis, pneumonia klebsiella and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. CANCIDAS dosage: unknown. During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM, AMIODARONE, DANAPAROID, NEFOPAM HYDROCHLORIDE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
Cancidas Side Effects Report #5448054-8
CANCIDAS problem was reported by a Consumer or non-health professional from POLAND on Aug 31, 2007. Male patient, weighting 8.82 lb, was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood urea increased, cardiac output, endocarditis, off label use, pneumonia, sepsis. CANCIDAS dosage: unknown. During the same period patient was treated with VANCOMYCIN, CILASTATIN AND IMIPENEM, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.
Cancidas Side Effects Report #5449483-9
Consumer or non-health professional from SPAIN reported CANCIDAS problem on Aug 30, 2007. Female patient, 50 years of age, was diagnosed with lower respiratory tract infection fungal, aplastic anaemia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus antibody positive, herpes simplex serology positive, jaundice, parvovirus b19 serology positive, respiratory failure. CANCIDAS dosage: 70 MG/DAILY. During the same period patient was treated with CYCLOSPORINE, SULFAMETHOXAZOLE TRIMETHOPRIM, MYOLASTAN, NAPROXEN. Patient was hospitalized. Patient died.
Cancidas Side Effects Report #5450964-2
CANCIDAS problem was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Sept 06, 2007. Male patient, 60 years of age, was diagnosed with aspergillosis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, acute respiratory distress syndrome, condition aggravated, pneumonia fungal, pulmonary haemorrhage, septic shock. CANCIDAS dosage: 70 MG/DAILY IV; 50 MG/DAILY IV. During the same period patient was treated with AMIKACIN SULPHATE, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, IMIPENEM, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TEICOPLANIN. Patient was hospitalized and became disabled. Patient died.
Cancidas Side Effects Report #5453195-5
Physician from MEXICO reported CANCIDAS problem on Sept 05, 2007. Male patient, 60 years of age, weighting 176.4 lb, was diagnosed with respiratory moniliasis, urinary tract infection fungal, renal failure, prophylaxis against gastrointestinal ulcer, pneumonia, analgesia, abdominal pain and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: jaundice. CANCIDAS dosage: unknown. During the same period patient was treated with FUROSEMIDE, OMEPRAZOLE, CEFTRIAXONE, AMIKACIN, CLONIXIN LYSINE, SCOPOLAMINE, NIMESULIDE. Patient recovered.
Cancidas Side Effects Report #5453204-3
CANCIDAS problem was reported by a Physician from AUSTRALIA on Sept 06, 2007. Male patient, 63 years of age, was diagnosed with antifungal prophylaxis, immunosuppression and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: klebsiella sepsis, leukaemia recurrent, retinitis. CANCIDAS dosage: unknown. During the same period patient was treated with PREDNISOLONE, MYCOPHENOLATE MOFETIL, VORICONAZOLE, TERBINAFINE. Patient died.
Cancidas Side Effects Report #5463647-X
Physician from COLOMBIA reported CANCIDAS problem on Sept 05, 2007. Male patient, 24 years of age, was diagnosed with candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: no therapeutic response. CANCIDAS dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient recovered.
Cancidas Side Effects Report #5468674-4
CANCIDAS problem was reported by a Consumer or non-health professional from SPAIN on Sept 14, 2007. Female patient, 50 years of age, was diagnosed with lower respiratory tract infection fungal, aplastic anaemia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, jaundice, respiratory failure. CANCIDAS dosage: 70 MG/DAILY IV. During the same period patient was treated with CYCLOSPORINE, SULFAMETHOXAZOLE TRIMETHOPRIM, MYOLASTAN, NAPROXEN. Patient was hospitalized. Patient died.
< Previous Showing 151-162 of 162